References in periodicals archive ?
Both the APC and PreSAP studies were designed with high statistical power to assess the effect on polyp recurrence.
An asterisk to his overall conclusion was the issue of the 400mg, once-daily dose of celecoxib prescribed in the PreSAP study, which, taken on its own, did not show a statistically significant elevation in the composite end point of any fatal or nonfatal cardiovascular event.
Levin's overall conclusion was the issue of the 400-mg, once-daily dose of celecoxib prescribed in the PreSAP study, which, taken on its own, did not show a statistically significant elevation in the composite end point of any fatal or nonfatal cardiovascular event.